Table 1.

Demographic characteristics of subjects completing the passive prophylaxis series and receiving the ETEC B7A challenge.

	Non-Hyperimmune	Anti-CS6	Anti-B7A
N	20	19	20
Age, Standard Deviation	34.8 (8.8)	32.2 (8.5)	35.9 (8.0)
Gender, N (%)
Female	9 (45.0)	8 (41.2)	4 (20.0)
Male	11 (55.0)	11 (57.9)	16 (80.0)
Race, N (%)
African-American	15 (75.0)	14 (73.7)	18 (90.0)
Caucasian	3 (15.0)	5 (26.3)	2 (10.0)
Other	2 (10.0)	0 (0.0)	0 (0.0)
Ethnicity, N (%)
Hispanic or Latino	3 (15.0)	3 (15.8)	1 (5.0)
Not Hispanic or Latino	17 (85.0)	16 (84.2)	19 (95.0)